Results 1 to 2 of 2

Thread: NNE Pharmaplan Expands in India

  1. #1
    Author Guest

    NNE Pharmaplan Expands in India

    NNE Pharmaplan expands its activities in India


    14 November 2008

    Today NNE Pharmaplan announced the official opening of a new office in Mumbai, India. By expanding its activities in India, one of the world’s largest medicine-producing markets, NNE Pharmaplan takes an important step towards meeting the fast-growing demand for specialised engineering and consulting services from the pharma and biotech industries in the region.

    India is a key strategic region for NNE Pharmaplan, with high growth rates and attractive market opportunities for the life science industry. Today, more than 20% of the world’s generic medicines are already produced in India, and the country has now more manufacturing sites approved by the US Food & Drug Administration (FDA) than any other country in the world outside the USA. With the addition of the Mumbai office, NNE Pharmaplan is now represented in the three most important economic development areas in the country, including also New Delhi and Bangalore.

    “We experience an increasing demand for our specialised services as many pharmaceutical companies in India are preparing to take advantage of the growing market opportunities. Either by expanding and upgrading existing facilities or by establishing new internationally approved development and production sites. In both cases we are specialised in providing our clients with efficient and high-quality solutions to meet these challenges”, said Hans Ole Voigt, CEO of NNE Pharmaplan.

    “India is attracting an increasing number of large international pharma and biotech companies, who wish to explore the business opportunities in the region. The cost of establishing and running manufacturing facilities in India is extremely competitive. In addition to this, India has a very large and highly skilled workforce, which makes it attractive for international companies to focus on India in their globalisation activities. With our strong presence in the country, we are ready to facilitate these companies’ efforts as well as serving the growing domestic industry”, said Hans Ole Voigt.

    NNE Pharmaplan officially celebrates the opening of the new office by hosting a two-day symposium in Mumbai about technology trends for modern pharmaceutical facilities with participation of a wide range of Indian and international specialists.

    ____________________
    About NNE Pharmaplan
    NNE Pharmaplan is the world’s leading engineering and consulting company focused exclusively on the pharma and biotech industries.

    NNE Pharmaplan covers the entire pharmaceutical supply chain from product development to manufacturing with know-how, expertise and well-proven solutions founded on more than 80 years of experience in the life science industry.

    Headquartered in Denmark, NNE Pharmaplan employs more than 1500 people at over 20 locations around the world, offering global reach and local knowledge in all major pharma and biotech markets. NNE Pharmaplan is a company in the Novo Group.

    For more information, please visit:
    https://edir.bulk-online.com/profile...pharmaplan.htm
    Attached Thumbnails Attached Thumbnails Click image for larger version. 

Name:	Pharmaplan.jpg 
Views:	467 
Size:	34.5 KB 
ID:	11418  

  2. Great to know about your expansion

    Quote Originally Posted by Author View Post
    NNE Pharmaplan expands its activities in India


    14 November 2008

    Today NNE Pharmaplan announced the official opening of a new office in Mumbai, India. By expanding its activities in India, one of the world’s largest medicine-producing markets, NNE Pharmaplan takes an important step towards meeting the fast-growing demand for specialised engineering and consulting services from the pharma and biotech industries in the region.

    India is a key strategic region for NNE Pharmaplan, with high growth rates and attractive market opportunities for the life science industry. Today, more than 20% of the world’s generic medicines are already produced in India, and the country has now more manufacturing sites approved by the US Food & Drug Administration (FDA) than any other country in the world outside the USA. With the addition of the Mumbai office, NNE Pharmaplan is now represented in the three most important economic development areas in the country, including also New Delhi and Bangalore.

    “We experience an increasing demand for our specialised services as many pharmaceutical companies in India are preparing to take advantage of the growing market opportunities. Either by expanding and upgrading existing facilities or by establishing new internationally approved development and production sites. In both cases we are specialised in providing our clients with efficient and high-quality solutions to meet these challenges”, said Hans Ole Voigt, CEO of NNE Pharmaplan.

    “India is attracting an increasing number of large international pharma and biotech companies, who wish to explore the business opportunities in the region. The cost of establishing and running manufacturing facilities in India is extremely competitive. In addition to this, India has a very large and highly skilled workforce, which makes it attractive for international companies to focus on India in their globalisation activities. With our strong presence in the country, we are ready to facilitate these companies’ efforts as well as serving the growing domestic industry”, said Hans Ole Voigt.

    NNE Pharmaplan officially celebrates the opening of the new office by hosting a two-day symposium in Mumbai about technology trends for modern pharmaceutical facilities with participation of a wide range of Indian and international specialists.

    ____________________
    About NNE Pharmaplan
    NNE Pharmaplan is the world’s leading engineering and consulting company focused exclusively on the pharma and biotech industries.

    NNE Pharmaplan covers the entire pharmaceutical supply chain from product development to manufacturing with know-how, expertise and well-proven solutions founded on more than 80 years of experience in the life science industry.

    Headquartered in Denmark, NNE Pharmaplan employs more than 1500 people at over 20 locations around the world, offering global reach and local knowledge in all major pharma and biotech markets. NNE Pharmaplan is a company in the Novo Group.

    For more information, please visit:
    https://edir.bulk-online.com/profile...pharmaplan.htm

    It sounds great ton know that NNE Pharmaplan is focussing on India and have plans to open office here in India... We are Chandigarh based Pharma Company Biomorph Lifesciences who offer pharma franchise on pcd basis.. We might be intresting in your services...do contact us ...https://www.pharmafranchise.net.in/

Similar Threads

  1. HAVER IBAU INDIA Expands
    By Author in forum Company News
    Replies: 0
    Last Post: 22nd August 2012, 15:37
  2. UWT Expands Worldwide
    By Author in forum Company News
    Replies: 0
    Last Post: 10th March 2012, 14:57
  3. Port of Newcastle, NSW Expands
    By Author in forum Company News
    Replies: 0
    Last Post: 18th August 2010, 17:00
  4. KSW Microtec Expands
    By Author in forum Company News
    Replies: 0
    Last Post: 15th December 2009, 17:17
  5. British Rema Expands
    By Author in forum Company News
    Replies: 0
    Last Post: 21st May 2009, 12:04

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Single Sign On provided by vBSSO